If the Apple Watch’s heart rate monitor proves accurate for detecting sensitive heart signals, it could help identify arrhythmias, abnormal heart rhythms that show no external symptoms but increase a patient’s risk for blood clots and strokes, among other complications.
A clinical study to investigate whether the Apple Watch can detect arrhythmias in a cohort of people is set to begin later this year, a source familiar with the matter told CNBC.
American Well declined to comment on its involvement with Apple to CNBC. Apple also declined CNBC‘s request for comment and Stanford did not return CNBC‘s request for comment.
Apple is slated to announce a new product line Tuesday. This story will be updated as more information becomes available.
More articles on health IT:
The next step in data analytics: Getting from historical to actionable analytics
Viewpoint: Agencies should look to HIPAA to promote data exchange
Children’s Hospital Colorado alerts 3.4k patients of email breach
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
